GIM
AMED

Glenmede Investment Management’s Amedisys AMED Stock Holding History

Glenmede Investment Management’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-166
Closed -$16.3K – 1440
2025
Q2 		$16.3K Buy
+166
New +$15.7K ﹤0.01% 1434

Other funds holding AMED

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MCI
MRP Capital Investments Alpharetta, Georgia $115M AUM 48.08% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Glenmede Investment Management's AMED Position: Q3 2025 in Review

Glenmede Investment Management sold out of Amedisys (AMED) in Q3 2025, closing a stake of 166 shares — an estimated $16.3K sold.

Glenmede Investment Management first reported a position in AMED in Q2 2025 and held it in 1 quarter. The position peaked at $16.3K in Q2 2025. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

  • Glenmede Investment Management reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
  • Glenmede Investment Management sold 166 Amedisys shares in Q3 2025, an estimated $16.3K.
  • Glenmede Investment Management first reported a position in Amedisys in Q2 2025 and held it in 1 quarter.
  • Glenmede Investment Management's Amedisys position peaked at $16.3K in Q2 2025.
  • 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on Glenmede Investment Management's 13F filing for Q3 2025, filed 13 Nov 2025.